-
Spectrum Pharma Q1 Loss $2.8 Mln Or $0.05/shr Vs. Profit $46.5 Mln Or $0.71/shr Last Year
5/9/2013
|
-
Law Offices Of Todd Garber Announces Investigation Of Spectrum Pharmaceuticals
4/12/2013
|
-
Saxena White P.A. Files Securities Fraud Class Action Against Spectrum Pharma In US District Court Of Nevada
4/11/2013
|
|
|
-
Spectrum Pharma Says Begins Phase 2 Study Of SPI-2012 For Treatment Of Chemotherapy-Induced Neutropenia
4/8/2013
|
-
Hagens Berman Notifies Spectrum Pharma Investors Of Pending Class-Action Lawsuit And May 13 Lead Plaintiff Deadline
3/22/2013
|
|
|
|
|
-
Ligand Pharma Signs License And Supply Deals With Spectrum Pharma For Captisol-enabled Melphalan
3/14/2013
|
-
RBC Capital Markets Is Lowering Spectrum Pharmaceuticals Inc (SPPI) 4Q13 Rev. Estimate To 59.9 M From 83.7 M
3/13/2013
|